380 related articles for article (PubMed ID: 26520037)
1. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
[TBL] [Abstract][Full Text] [Related]
2. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
4. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
5. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
6. Severe cutaneous adverse reactions to drugs.
Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
[TBL] [Abstract][Full Text] [Related]
7. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
8. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
9. Acute Generalized Exanthematous Pustulosis Simulating Toxic Epidermal Necrolysis: Overlapping Processes.
García Abellán J; Matarredona Catalá J; Jaen Larrieu A; Valencia Ramírez I
Actas Dermosifiliogr (Engl Ed); 2018 Jun; 109(5):460-462. PubMed ID: 29402393
[No Abstract] [Full Text] [Related]
10. Severe adverse drug reactions.
Teo YX; Walsh SA
Clin Med (Lond); 2016 Feb; 16(1):79-83. PubMed ID: 26833523
[TBL] [Abstract][Full Text] [Related]
11. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
[TBL] [Abstract][Full Text] [Related]
12. Immune Reactions in Major Types of Oncological Treatment.
Kozubek P; Wołoszczak J; Gomułka K
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511017
[TBL] [Abstract][Full Text] [Related]
13. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
[TBL] [Abstract][Full Text] [Related]
14. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature.
Peermohamed S; Haber RM
Arch Dermatol; 2011 Jun; 147(6):697-701. PubMed ID: 21690532
[TBL] [Abstract][Full Text] [Related]
15. [Identification of cutaneous adverse drug reactions].
Ingen-Housz-Oro S
Rev Prat; 2023 Mar; 73(3):307-313. PubMed ID: 37289124
[TBL] [Abstract][Full Text] [Related]
16. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis in patients with psoriasis.
Smith VM; Pollock B; Wilkinson SM; Rose RF
Clin Exp Dermatol; 2016 Jul; 41(5):561-2. PubMed ID: 26931079
[No Abstract] [Full Text] [Related]
17. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
[TBL] [Abstract][Full Text] [Related]
18. Adverse cutaneous drug eruptions: current understanding.
Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
[TBL] [Abstract][Full Text] [Related]
19. Drug Hypersensitivity Reactions.
Wilkerson RG
Immunol Allergy Clin North Am; 2023 Aug; 43(3):473-489. PubMed ID: 37394254
[TBL] [Abstract][Full Text] [Related]
20. An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions.
Gelincik A; Cavkaytar O; Kuyucu S
Curr Pharm Des; 2019; 25(36):3881-3901. PubMed ID: 31692425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]